tiprankstipranks
Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market
ATHE
Alterity Therapeutics
RESEARCH TOOLSreports
Want to see ATHE full AI Analyst Report?

Alterity Therapeutics (ATHE) Stock News & Sentiment

302 Followers
Alterity Therapeutics Data Underpin Phase 3 Advancement of ATH434 in Multiple System Atrophy
Premium
Company Announcements
Alterity Therapeutics Data Underpin Phase 3 Advancement of ATH434 in Multiple System Atrophy
3d ago
6K
ATHE
Alterity Therapeutics Files May 2026 Form 6-K, Releases New Corporate Presentation
Premium
Company Announcements
Alterity Therapeutics Files May 2026 Form 6-K, Releases New Corporate Presentation
10d ago
6K
ATHE
Alterity Therapeutics Highlights MRI Biomarker Breakthrough as It Prepares Phase 3 MSA Program
Premium
Company Announcements
Alterity Therapeutics Highlights MRI Biomarker Breakthrough as It Prepares Phase 3 MSA Program
11d ago
6K
ATHE
Alterity Therapeutics Reports Change in Substantial Holding by Regal Funds
Premium
Company Announcements
Alterity Therapeutics Reports Change in Substantial Holding by Regal Funds
7M ago
6K
ATHE
Promising Phase 2 Results for ATH434 Boost Alterity Therapeutics’ Buy Rating
Premium
Ratings
Promising Phase 2 Results for ATH434 Boost Alterity Therapeutics’ Buy Rating
7M ago
ATHE
Alterity Therapeutics Reports Positive ATH434 Phase 2 Trial Results at 2025 MDS Congress
Premium
Company Announcements
Alterity Therapeutics Reports Positive ATH434 Phase 2 Trial Results at 2025 MDS Congress
8M ago
6K
ATHE
Alterity Therapeutics Sets AGM and Director Nomination Dates
Premium
Company Announcements
Alterity Therapeutics Sets AGM and Director Nomination Dates
8M ago
6K
ATHE
More ATHE News >

ATHE News on the Web

Alterity Therapeutics Data Underpin Phase 3 Advancement of ATH434 in Multiple System Atrophy
TipRanks News
Bullish
Alterity Therapeutics Files May 2026 Form 6-K, Releases New Corporate Presentation
TipRanks News
Neutral
Alterity Therapeutics publishes quantitative susceptibility mapping MRI data
TipRanks News
Bullish
Alterity Therapeutics Highlights MRI Biomarker Breakthrough as It Prepares Phase 3 MSA Program
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Alterity Therapeutics (ATHE) and Moderna (MRNA)
TipRanks News
Neutral
Alterity Therapeutics receives FDA feedback after second ATH434 Type C meeting
TipRanks News
Bullish
Alterity Therapeutics presents new data analyses from ATH434 trial
TipRanks News
Bullish
Alterity Therapeutics appoints Cunningham to Board of Directors
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ATHE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATHE’s Media Buzz Sentiment?
1 articles about ATHE were published this week. In an average week, 1.5 articles are published.
    What is ATHE’s weekly average amount of articles?
    In an average week, 1.5 articles about ATHE are published.
      What is ATHE’s News Sentiment?
      100% of articles about ATHE were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        Showing the stocks with the most bullish news sentiment over the past week